Brief: Ultimovacs Updates On Possible Impact Of Covid-19

Zelluna ASA

20/03/2020 16:06

March 20 (Reuters) - Ultimovacs ASA  ULTIMO.OL :
    * POSSIBLE IMPLICATIONS OF THE CORONAVIRUS (COVID-19)
    * ON CORONAVIRUS: INITIATION, PATIENT INCLUSION AND CONDUCT OF CLINICAL TRIALS WILL BE
AFFECTED
    * SUPPLY CHAIN FOR INVESTIGATIONAL PRODUCTS MAY BE INTERRUPTED, EITHER AT MANUFACTURING SITE
OR
WITH RESPECT TO LOGISTICAL OPERATIONS
    * IMMEDIATE CONSEQUENCE OF CORONAVIRUS PANDEMIC IS THAT CLINICAL TRIAL ACTIVITIES AND
PATIENT
INCLUSION IS NOW PUT ON HOLD
    * ULTIMOVACS EXPECTS SUPPLIES OF INVESTIGATIONAL PRODUCTS TO BE UNDER CONTROL
    * ULTIMOVACS EXPECTS MAIN CONSEQUENCES OF CORONOVIRUS PANDEMIC TO BE IMPLICATIONS ON TIMING
AND
COSTS

Source text for Eikon:  ID:nObiLZbFRa 
Further company coverage:  ULTIMO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))